C

조아제약

034940KOSDAQ의약품 제조업

40.3 / 100

Reference Date: 2026-04-13

Financial Score7.5 / 40
News Sentiment18.8 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Slightly down 2.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Joa Pharmaceutical, established in 1988, primarily engages in the production and sale of general pharmaceuticals, health functional foods, and is developing pet pharmaceuticals and nutritional supplements. It operates a nationwide pharmacy franchise, Medipham, and supplies over 200 products, including liver disease treatment drug Hepatos, memory improvement drug Joa Baiton, and children's health beverage Jalketon. The company has been exporting its products to 23 countries, including Vietnam, China, and the U.S., since 1995.

Number of Employees

243people

Average Salary

62.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 14.804.0Point
PBR
1.26Industry Average 1.042.5Point

Higher than industry avg (caution)

ROE
-29.26Industry Average 4.420.0Point

Well below industry avg

Debt Ratio
32.88Industry Average 11.980.0Point

2.7x industry avg (risky)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼2.9% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼4.8% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -28.1% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position1.0Point

Near 52w low (18%, downtrend)

Current 886Won52-week high 1,26952-week low 800
1-month return2.0Point

1m -2.74% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral정기주주총회결과2026-03-23